Increased risk of herpes zoster in diabetic patients comorbid with coronary artery disease and microvascular disorders: A population-based study in Taiwan

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Ke, Chi Chen ^a   Lai, Hui Chin ^a   Lin, Ching Heng ^a   Hung, Chih Jen ^a   Chen, Der Yuan ^a   Sheu, Wayne H H ^a   Lui, Ping Wing ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; GLITAZONE DERIVATIVE; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; GLYCOSIDASE INHIBITOR; INULIN;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DISEASE ASSOCIATION; FEMALE; HERPES ZOSTER; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TAIWAN; ADOLESCENT; CASE CONTROL STUDY; COMPLICATION; DIABETES COMPLICATIONS; FACTUAL DATABASE; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; VASCULAR DISEASE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; COMORBIDITY; CORONARY ARTERY DISEASE; DATABASES, FACTUAL; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; GLYCOSIDE HYDROLASE INHIBITORS; HERPES ZOSTER; HUMANS; HYPOGLYCEMIC AGENTS; INULIN; MALE; METFORMIN; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SULFONYLUREA COMPOUNDS; TAIWAN; THIAZOLIDINEDIONES; VASCULAR DISEASES; YOUNG ADULT;

EID: 84954539965     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146750     Document Type: Article

References (28)

1. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev. 1996; 9: 361-381 PMID: 8809466
2. Cohen JI. Clinical practice: Herpes zoster. N Engl J Med. 2013; 369: 255-263. doi: 10.1056/NEJMcp1302674 PMID: 23863052
3. Lungu O, Annunziato PW, Gershon A, Staugaitis SM, Josefson D, La Russa P, et al. Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc Natl Acad Sci USA. 1995; 92(24): 10980-10984. PMID: 7479921
4. Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014; 4: e004833. doi: 10.1136/bmjopen-2014-004833 PMID: 24916088
5. Guignard AP, Greenberg M, Lu C, Rosillon D, Vannappagari V. Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997-2006. Infection. 2014; 42: 729-735. doi: 10.1007/s15010-014-0645-x PMID: 24973980
6. Struijs JN, Baan CA, Schellevis FG, Westert GP and van den Bos GAM. Comorbidity in patients with diabetes mellitus: impact on medical health care utilization. BMC Health Services Research. 2006; 6:84. PMID: 16820048
7. Asia Pacific Cohort Studies Collaboration. Cholesterol, diabetes and major cardiovascular diseases in the Asia-Pacific region. Diabetologia. 2007; 50: 2289-2297. PMID: 17909878
8. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979; 59: 8-13. PMID: 758126
9. Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev. 1987; 3: 463-524. PMID: 3552530
10. Joesoef RM, Harpaz R, Leung J, Bialek SR. Chronic medical conditions as risk factors for herpes zoster. Mayo Clin Proc. 2012; 87: 961-967. doi: 10.1016/j.mayocp.2012.05.021 PMID: 23036671
11. Breuer J, Pacou M, Gauthier A, Brown M. Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK. Neurology. 2014; 82: 206-212. doi: 10.1212/WNL.0000000000000038 PMID: 24384645
12. Jih JS, Chen YJ, Lin MW, Chen YC, Chen TJ, Huang YL, et al. Epidemiological features and costs of herpes zoster in Taiwan: a national study 2000 to 2006. Acta Derm Venereol. 2009; 89: 612-616. doi: 10.2340/00015555-0729 PMID: 19997693
13. Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg. 2010; 126: 2234-2242. doi: 10.1097/PRS.0b013e3181f44abc PMID: 20697313
14. Heymann AD, Chodick G, Karpati T, Kamer L, Kremer E, Green MS, et al. Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection. 2008; 36: 226-230. doi: 10.1007/s15010-007-6347-x PMID: 18454342
15. Nagasako EM, Johnson RW, Griffin DR, Elpern DJ, Dworkin RH Geographic and racial aspects of herpes zoster. J Med Virol. 2003; 70: S20-23. PMID: 12627482
16. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis. 2004; 4: 26-33 PMID: 14720565
17. Vossen MT, Gent MR, Weel JF, de Jong MD, van Lier RA, Kuijpers TW. Development of virus-specific CD4+ T cells on reexposure to varicella-zoster virus. J Infect Dis. 2004; 190: 72-82. PMID: 15195245
18. Park HB, Kim KC, Park JH, Kang TY, Lee HS, Kim TH, et al. Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus. J Rheumatol. 2004; 31: 2151-2155. PMID: 15517626
19. Pedicino D, Liuzzo G, Trotta F, Giglio AF, Giubilato S, Martini F, et al. Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus. J Diabetes Res. 2013; 184258. doi: 10.1155/2013/184258 PMID: 23762872
20. Pedicino D, Giglio AF, Galiffa VA, Trotta F, Liuzzo G. Type 2 diabetes, immunity and cardiovascular risk: a complex relationship. In: Oluwafemi O, ed. Pathophysiology and Complications of Diabetes Mellitus. In Tech. 2012. 45-70.
21. Legein B, Temmerman L, Biessen EA, Lutgens E. Inflammation and immune system interactions in atherosclerosis. Cell Mol Life Sci. 2013; 70: 3847-3869. doi: 10.1007/s00018-013-1289-1 PMID: 23430000
22. Giubilato S, Liuzzo G, Brugaletta S, Pitocco D, Graziani F, Smaldone C, et al. Expansion of CD4+CD28 null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. Eur Heart J. 2011; 32: 1214-1226. doi: 10.1093/eurheartj/ehq499 PMID: 21217142
23. Backteman K. T cells and NK cells in coronary artery disease: longitudinal and methodological studies in humans. Linköping: Linköping University Electronic Press; 2014. Linköping University Medical Dissertations, 1409.
24. Nagel MA. Varicella zoster virus vasculopathy: clinical features and pathogenesis. J Neurovirol. 2014; 20: 157-163. doi: 10.1007/s13365-013-0183-9 PMID: 23918503
25. Jacob HS, Visser M, Key NS et al. Herpes virus infection of the endothelium: new insights into atherosclerosis. Trans Am Clin Climatol Assoc 1992; 103:95-104. PMID: 1329303
26. Xiu F, Stanojcic M. Stress hyperglycemia, insulin treatment, and innate immune cells. Int J Endocrinol. 2014; 2014: 486403. doi: 10.1155/2014/486403 PMID: 24899891
27. Peleg AY, Weerarathna T, McCarthy JS, Davis TM. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev. 2007; 23: 3-13. PMID: 16960917
28. Scheen AJ, Esser N, Paquot N. Antidiabetic agents: potential anti-inflammatory activity beyond glucose control. Diabetes Metab. 2015: 02.003.